Home › NCT05525923

Personalized Postoperative Pain Management Following Thoracic Surgery in Adults

Pharmacogenetics and Pharmacokinetics of Oxycodone to Personalize Postoperative Pain Management Following Thoracic Surgery in Adults

Who can join

Ages 18 to 99 · All sexes

Inclusion Criteria:

* \>18 years
* American Society of Anesthesiologists (ASA) Physical Status 1, 2, 3
* Undergoing thoracic surgery (TS; pneumonectomy, lobectomy and segmentectomy)

Exclusion Criteria:

* Children (\<18 years)
* Pregnant women
* American Society of Anesthesiologists (ASA) Physical Status 4 or above
* Non-English speaking
* Outpatient surgery
* Concomitant additional surgical procedures
* Significant liver and kidney dysfunction
* Significant cardiorespiratory compromise
* Patients with polysubstance use (e.g., cocaine, marijuana, amphetamine, etc.)

About the study

The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone, in adults following thoracic surgery. Major inpatient thoracic surgeries (TS) for lung disease are common and extremely painful surgeries and are associated with sever post-surgical pain, high incidence of chronic post-surgical pain (CPSP), excess opioid use, costly immediate postoperative opioid adverse events (AEs), and long hospital stays. This study is aiming to develop proactive risk prediction algorithms for precision surgical pain relief in adult TS patients through comparison of actual clinical outcomes with standard of care to predicted outcomes based on personalized risk assessments.

Sponsor: OpalGenix, Inc · Participants: 200 · Started: Nov 30, 2023

Contact the study team

• Amy Monroe, MPH, MBA · Phone: 412-623-6382
• Alisha Maslanka, BS · Phone: 412-864-6779

Official record on ClinicalTrials.gov — NCT05525923

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.